483 King Pharmaceuticals. Aug 2014

483 King Pharmaceuticals. Aug 2014

Michele Forster FDA, Emily Orban FDA$119.00 - Available Now

FDA investigators audited the King Pharmaceuticals. - Rochester, MI, United States facility and issued 5 inspectional observations (via FDA 483) on 26 Aug 2014.

Product details

  • Category: Human Drugs
  • Number of Observations: 5
  • Inspection end: 26 Aug 2014
  • Location: Rochester, United States
  • FEI: 1876582
Add To Cart